Sort
21,281 grants matching “influenza”
Mitigation of Highly pathogenic influenza (HPAI) in milk and dairy products
$1,150,000Diego G Diel · Cornell University · U18 · FY2024 · FD
Immunophenotyping for COVID-19 Cohort (IMPACC)
$1,149,216David A. Hafler · Yale University · U19 · FY2021 · AI
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2020 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2017 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2019 · DA
Section on High Resolution Optical Imaging
$1,148,655Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2012 · EB
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
$1,148,204Anne Searls De Groot · Epivax, Inc. · R01 · FY2019 · AI
A functional evolutionary genetic approach to combat viral infection
$1,148,000John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2022 · AI
A functional evolutionary genetic approach to combat viral infection
$1,148,000John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2023 · AI
A functional evolutionary genetic approach to combat viral infection
$1,148,000John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2024 · AI
Developing Teixobactin for Respiratory Infections
$1,147,950Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2023 · AI
A functional evolutionary genetic approach to combat viral infection
$1,147,708John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2021 · AI
Pacific Center for Emerging Infectious Diseases Research
$1,147,500Richard Yanagihara · University Of Hawaii At Manoa · P30 · FY2015 · GM
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES
$1,146,012Rustom Noshir Antia · Emory University · U01 · FY2023 · AI
Spirulina oral supplement for enhancing host resilience to virus infection
$1,145,795Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2024 · AT
Collaborative Modeling for Assessment and Optimization in Public Health
$1,144,898Marc Lipsitch · Harvard School Of Public Health · U54 · FY2014 · GM
New Strategies to Prevent Death from Influenza
$1,144,813Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2008 · AI
A functional evolutionary genetic approach to combat viral infection
$1,144,500John W. Schoggins · Ut Southwestern Medical Center · DP1 · FY2020 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)-mRNA-1273-P204 Moderna Pediatric Study
$1,144,400Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,143,757Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2021 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,142,044Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2017 · AI
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$1,141,522Sallie R. Permar · Duke University · P01 · FY2016 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,141,009Mario Barro · Global Vaccines, Inc. · U01 · FY2008 · AI
Clinical Studies of Vaccines for Pandemic H1N1 Influenza
$1,140,889Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con
$1,138,296Arnold S Monto · University Of Michigan At Ann Arbor · U18 · FY2010 · IP